Literature DB >> 18628666

Enhancement of glutamate uptake in 1-methyl-4-phenylpyridinium-treated astrocytes by trichostatin A.

Jia-Yong Wu1, Feng-nan Niu, Rong Huang, Yun Xu.   

Abstract

Histone deacetylases (HDAC) inhibitors have been emerging as neuroprotective agents by acting on neurons and microglia. In this study, we found trichostatin A (TSA), a HDAC inhibitor, could inhibit the elevation of glutamate in 150 microM 1-methyl-4-phenylpyridinium (MPP+)-treated primary cultured astrocytes medium when its concentration reached 132 nM. TSA of 132 nM or more could promote the uptake of [3H]-D, L-glutamate by astrocytes. Further study showed the downregulation of glutamate transporter 1 and glutamate/aspartate transporter induced by MPP+ were prevented by TSA. Therefore, these findings suggested TSA could alleviate MPP+-induced impairment of astrocytic glutamate uptake, which might be a novel mechanism contributing to neuroprotection by HDAC inhibitors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628666     DOI: 10.1097/WNR.0b013e328308b355

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

1.  Histone deacetylase inhibitors preserve white matter structure and function during ischemia by conserving ATP and reducing excitotoxicity.

Authors:  Selva Baltan; Sean P Murphy; Camelia A Danilov; Amelia Bachleda; Richard S Morrison
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

Review 2.  HDAC inhibitors and neurodegeneration: at the edge between protection and damage.

Authors:  Karen C Dietz; Patrizia Casaccia
Journal:  Pharmacol Res       Date:  2010-02-01       Impact factor: 7.658

3.  Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes.

Authors:  Tatjana Perisic; Nicole Zimmermann; Thomas Kirmeier; Maria Asmus; Francesca Tuorto; Manfred Uhr; Florian Holsboer; Theo Rein; Jürgen Zschocke
Journal:  Neuropsychopharmacology       Date:  2009-11-18       Impact factor: 7.853

Review 4.  Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative Diseases.

Authors:  Nuraqila Mohd Murshid; Faridah Aminullah Lubis; Suzana Makpol
Journal:  Cell Mol Neurobiol       Date:  2020-10-19       Impact factor: 5.046

5.  Excitotoxicity and mitochondrial dysfunction underlie age-dependent ischemic white matter injury.

Authors:  Selva Baltan
Journal:  Adv Neurobiol       Date:  2014

6.  The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ.

Authors:  Sadayuki Hashioka; Andis Klegeris; Patrick L McGeer
Journal:  J Neuroinflammation       Date:  2012-05-30       Impact factor: 8.322

Review 7.  Targeting histone deacetylases: a novel approach in Parkinson's disease.

Authors:  Sorabh Sharma; Rajeev Taliyan
Journal:  Parkinsons Dis       Date:  2015-01-28

Review 8.  Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease.

Authors:  Yunlong Zhang; Feng Tan; Pingyi Xu; Shaogang Qu
Journal:  Neural Plast       Date:  2016-02-14       Impact factor: 3.599

9.  Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson's disease model.

Authors:  Yunlong Zhang; Xiaoliang He; Xingjun Meng; Xiaojuan Wu; Huichun Tong; Xiuping Zhang; Shaogang Qu
Journal:  Cell Death Dis       Date:  2017-02-02       Impact factor: 8.469

Review 10.  Epigenetic Regulation of Neuroinflammation in Parkinson's Disease.

Authors:  Madiha Rasheed; Junhan Liang; Chaolei Wang; Yulin Deng; Zixuan Chen
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.